IONTOX

We are experts in building and applying complex models of human tissues for drug discovery. We are cell biologists, tissue physiologists and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data. We carry out in vitro studies or provide products that enable customers to generate data on efficacy, safety and transport to de-risk discovery and development. Our experts collaborate with customers to design studies to provide data that answer critical questions for pre-clinical drug development. We run the study, provide and interpret the data, or we can supply products and support you in your in-house studies. We aim to contribute to the development of new innovative therapies by delivering services, products and tools based on our models of human tissues that provide data that informs and predicts how these therapies will behave in humans. Newcells mission is to de-risk the decision-making process in drug development by providing physiologically relevant in vitro models that most accurately predict in vivo outcomes. Globally recognised scientific expertise in cell physiology and organoid technology is embedded in all products & services.

Trusted by researchers and scientists worldwide, our cells are consistently cited in research publications, attesting their quality and dependability. We offer iPSC reprogramming, Cas9 genome editing, directed differentiation, custom cell isolation, in vitro assays, and ASO screening services. Our team of PhD scientists provides disease-relevant, patent-derived models that accelerate drug discovery and disease understanding. We specialize in complex assay development and execution for research support. Our expertise includes multi-cellular model building, 3D liver model signaling studies, and compound screening for iPSC-derived neurons and human immune cells.

Lifeline® Cell Technology (Lifeline®) specializes in the development and manufacture of purified primary human cells and optimized reagents for cell culture. Lifeline® is a wholly owned subsidiary of International Stem Cell Corporation (ISCO, ISCO.OB), a public stem cell therapeutics company based in Oceanside, CA. Lifeline® production and administrative facilities are located in Frederick, MD. If Lifeline® products do not meet our posted performance and quality standards, we will replace them at no charge or provide a full refund. Upon request, Lifeline® will provide lot specific QC test results, material safety data sheets, and certificates of analysis. Lifeline® products are For Research Use Only and are not approved for human or veterinary use, or for use in in vitro diagnostic or in clinical procedures. Lifeline® Cell Technology, a leading provider of primary human cells and optimized cell culture media, is pleased to announce its collaboration with Science Exchange, a renowned affiliate marketplace. This partnership enables our valued prospects and customers to conveniently purchase our high-quality products through Science Exchange’s platform.

CellBioasis can facilitate your R&D innovations to help you enhance the quality of care and improve overall healthcare cost efficiencies. CellBioasis is a highly specialised distribution set-up which supports the scientific community to innovate better and complement Human Health. We are creating Healthcare Industry delight by offering the best Life Sciences solutions through the highest delivery standards, by being highly responsive and by leading through co-creativity. As we are preferred Life Science Partner for leading Global Brands. We are creating Healthcare Industry delight by offering the best Life Sciences solutions. CellBioasis was started with a passion to create revolutionary Life sciences industry solutions to support advanced next-generation discovery. We are on a mission to offer the finest tools, powered by an excellent distribution network to facilitate research and development for the betterment of human health. We are an agile team, deeply driven by research, high on responsiveness and committed to offering the most optimised and on-time delivery solutions for our partners.

We are a leading supplier of more than 270 different types of primary human cells, animal cells, RNA, DNA and cell-based assays. We are a leading global supplier of more than 270 different types of primary human and animal cell-based products for life science research, drug development, screening of chemicals and biomaterials development. We discover, develop and distribute cell-based products and services for life science research, drug development and tissue engineering. We offer a variety of 'ready-to-use' high-value primary human cells, animal cells, RNA, DNA, cell culture media and cell-based assays. We help scientists be more productive, more competitive and more innovative.

Transcell has been on an epic ride ever since it's operations started in 2011. Our in-house R&D direction aligned with global advancements has helped us to redefine, reposition Transcell Biolife’s biobanking offerings to serve it’s purpose: facilitating personalized, precision medicine since 2017. Biolife has built capacities to store donor and patients’ clinical grade progenitor cellular platforms, microphysiological systems, derived genetic material, acquired omics data finding applications in both standard care and clinical research. Today Biolife has the integrated offerings personalizing cell transplantations, treating blood and related cancers. To offer Transformative Medicinal applications from a next generation Biobank in and from India. Genomics based personalized disease prevention approach offers a system for integrated risk profiling and individualizing health management.